Core Points - The Shenzhen-Hong Kong Medical Index (983035) closed at 4494.42 points, up 0.15%, with a trading volume of 7.52 billion yuan and a turnover rate of 0.75% [1] - Among the index constituents, 32 stocks rose while 24 fell, with Medical Pulse leading the gainers at 3.65% and Health Road leading the decliners at 3.41% [1] Index Constituents Summary - The top ten constituents of the Shenzhen-Hong Kong Medical Index include: - Mindray Medical (14.56% weight, latest price 196.30 yuan, market cap 238 billion yuan, up 1.50%) [1] - Yier Eye Hospital (11.62% weight, latest price 11.40 yuan, market cap 106.31 billion yuan, down 0.26%) [1] - Lejin Medical (4.85% weight, latest price 15.87 yuan, market cap 29.26 billion yuan, up 0.13%) [1] - Aimeike (4.80% weight, latest price 146.26 yuan, market cap 44.26 billion yuan, up 0.83%) [1] - Yuyue Medical (4.66% weight, latest price 35.70 yuan, market cap 35.79 billion yuan, down 0.67%) [1] - Yingke Medical (3.64% weight, latest price 41.53 yuan, market cap 27.21 billion yuan, up 1.94%) [1] - Furuide (3.59% weight, latest price 67.08 yuan, market cap 17.78 billion yuan, up 1.36%) [1] - Meinian Health (3.58% weight, latest price 5.28 yuan, market cap 20.67 billion yuan, down 1.68%) [1] - Sinopharm (3.35% weight, latest price 18.42 yuan, market cap 57.48 billion yuan, down 0.69%) [1] - Ping An Good Doctor (2.63% weight, latest price 13.66 yuan, market cap 29.52 billion yuan, down 1.83%) [1] Capital Flow Analysis - The net outflow of main funds from the index constituents totaled 58.83 million yuan, while retail investors saw a net inflow of 78.07 million yuan [1] - Specific stock capital flows include: - Aimeike: Main fund net inflow of 46.99 million yuan, retail net outflow of 30.07 million yuan [2] - Mindray Medical: Main fund net inflow of 33.08 million yuan, retail net outflow of 17.11 million yuan [2] - Furuide: Main fund net inflow of 13.68 million yuan, retail net outflow of 19.08 million yuan [2] Recent Adjustments - The Shenzhen-Hong Kong Medical Index has undergone adjustments in the last 10 days, with one new stock added [2]

Market Overview - The medical services sector increased by 0.56% on November 25, with ST Zhongzhu leading the gains [1] - The Shanghai Composite Index closed at 3870.02, up 0.87%, while the Shenzhen Component Index closed at 12777.31, up 1.53% [1] Top Gainers in Medical Services - ST Zhongzhu (600568) closed at 2.57, up 4.90% with a trading volume of 53,900 shares and a turnover of 13.85 million yuan [1] - Chengda Pharmaceutical (301201) closed at 47.78, up 2.97% with a trading volume of 112,700 shares and a turnover of 540 million yuan [1] - Boji Pharmaceutical (300404) closed at 10.10, up 2.75% with a trading volume of 108,600 shares and a turnover of 10.9 million yuan [1] Top Losers in Medical Services - Jiuzhou Pharmaceutical (603456) closed at 18.75, down 0.85% with a trading volume of 181,100 shares and a turnover of 343 million yuan [2] - Tongce Medical (600763) closed at 41.95, down 0.66% with a trading volume of 49,600 shares and a turnover of 210 million yuan [2] - Yingkang Life (300143) closed at 10.12, down 0.49% with a trading volume of 44,700 shares and a turnover of 4.56 million yuan [2] Capital Flow Analysis - The medical services sector experienced a net outflow of 113 million yuan from institutional investors, while retail investors saw a net inflow of 30.37 million yuan [2][3] - Major stocks like WuXi AppTec (603259) had a net inflow of 67.13 million yuan from institutional investors, while Sunshine Nuohua (688621) saw a net outflow of 2.29 million yuan from retail investors [3] Summary of Individual Stock Performance - Sunshine Nuohua (688621) had a net inflow of 38.24 million yuan from institutional investors, but a net outflow of 3.59 million yuan from retail investors [3] - Chengda Pharmaceutical (301201) also saw a significant net inflow of 36.45 million yuan from institutional investors, with a net outflow of 13.58 million yuan from retail investors [3] - New Mileage (002219) had a net inflow of 14.15 million yuan from institutional investors, while retail investors experienced a net outflow of 6.70 million yuan [3]

Group 1 - The company, Xinli Cheng (002219), reported that as of November 10, 2025, the number of shareholders reached 70,358 [1]

Core Viewpoint - On November 17, a total of 17 listed companies will have their restricted shares unlocked, with a total market value of approximately 22.745 billion yuan [1] Summary by Category Restricted Shares Unlocking - The total number of restricted shares unlocking on this date is significant, with a total market value of about 22.745 billion yuan [1] - Specific companies and their respective unlocking details include: - Yingte Group (000411): 273,600 shares from equity incentive [1] - East China Pharmaceutical (000963): 1,630,300 shares from equity incentive [1] - Innovation New Materials (600361): 2.867 billion shares from other types [1] - Fida Environmental Protection (600526): 152 million shares with extended lock-up period [1] - New Mileage (002219): 8.7 million shares from equity incentive [1] - Anke Bio (300009): 12.3941 million shares from equity incentive [1] - Songcheng Performance (300144): 2.16 million shares from equity incentive [1] - Keheng Co., Ltd. (300340): 511,400 shares from equity incentive [1] - Haoxiangni (002582): 1 million shares from equity incentive [1] - Zhongzhi Technology (301361): 2.252 million shares from pre-issue [1] - Jack Co., Ltd. (603337): 2.4576 million shares from equity incentive [1] - Tian'ao Electronics (002935): 105,400 shares from equity incentive [1] - Huatuo Cable (605196): 556,000 shares from equity incentive [1] - Yongshuntai (001338): 266 million shares from pre-issue [1] - New World (301277): 149 million shares from pre-issue [1] - Yongxi Electronics (688362): 130 million shares [1] - Kangxi Communication (688653): 3.184 million shares [1]

Core Insights - The 2025 Super Hub Expo in Hong Kong marks a significant step in consolidating the city's position as an Asian transportation hub, showcasing the latest technologies and innovations in the transport and logistics sector [1] - The event aims to promote multimodal transport development and deepen regional cooperation, creating a favorable environment for Hong Kong's future role in the transport sector [1] Group 1: Event Overview - The expo features a three-day program that includes professional exchanges, business matching, and award ceremonies, effectively promoting cross-sector collaboration and sustainable development in the transport ecosystem [1] - Key figures from the industry, including representatives from the Civil Aviation Administration of China and the Hong Kong government, participated in the event, emphasizing its importance [1] Group 2: Government Support - The Chairman of the Hong Kong Airport Authority highlighted the necessity of continuous infrastructure investment for the future of the aviation industry, mentioning the three-runway system as a major project [7] - The event received strong support from various government departments, showcasing its significance in the industry and making the "Air Silk Road Forum" a focal point of the expo [7] Group 3: Industry Participation - The expo expanded its coverage to include air cargo, rail transport, and the emerging low-altitude economy, attracting over 100 leading brands such as ARUP, AECOM, and NEC [8] - More than 200 major airports, ground service companies, airlines, and civil aviation authorities participated, marking the initiation of numerous professional exchanges and business opportunities [9] Group 4: Business Networking - The expo aims to create a vibrant business ecosystem in the Asian multimodal transport sector, featuring various activities and high-quality networking opportunities [10] - Specific initiatives include GAD Asia for practical financing and sustainable airport business growth, closed-door airport dialogues for senior executives, and structured one-on-one business matching sessions [10] Group 5: Thematic Discussions - The expo includes over 100 thematic seminars covering topics such as sustainable transport, digital transformation, and green aviation technology, providing valuable learning and networking opportunities [12][13] - The "Low Altitude Economy Forum" emerged as a key highlight, supported by the Hong Kong government's regulatory sandbox policy, showcasing innovations in urban air mobility [14]

Group 1 - The Licheng New Mile Outpatient Department has lost its radiation therapy license copy, with certificate code: Lu Wei Fang Zheng Zi (2024) No. 370112-000030, and it is declared void [1] - Shi Guowei has lost three housing receipts issued by Heze Tianhua Real Estate Group Co., Ltd.: No. 0002436 (amount: 45,955 yuan), No. 0002437 (amount: 2,250 yuan), and No. 0002438 (amount: 10,000 yuan), and hereby declares the original documents void [1] - Li Yucai from Beidaogou Village, Zhonggong Town has lost the collective land use certificate No. Licheng Ji Jian (1992) Zi No. 051661254, and this is hereby announced [1]

Core Points - The launch of the Beijing International Arbitration Court Hong Kong Center marks a new milestone in legal and dispute resolution cooperation between Beijing and Hong Kong [1][3] - The establishment of the center coincides with the 30th anniversary of the Beijing International Arbitration Court, reflecting trust in Hong Kong's arbitration system and supporting the country's efforts in enhancing foreign-related legal construction [3] - The Hong Kong government's legal department has been actively promoting judicial cooperation with mainland mechanisms, establishing effective collaboration under the "One Country, Two Systems" principle [3] Summary by Categories Legal and Dispute Resolution - The Beijing International Arbitration Court Hong Kong Center is the first overseas branch of the court, emphasizing the importance of international commercial arbitration mechanisms [3] - The center's establishment is seen as a significant step in promoting high-level openness to the outside world [3] Judicial Cooperation - The Hong Kong legal department has implemented the "Preservation Arrangement" to facilitate cooperation between mainland and Hong Kong courts regarding arbitration procedures [3] - As of September this year, Hong Kong arbitration institutions have processed 177 applications under the Preservation Arrangement across 48 courts, with approved asset preservation applications totaling over 27.8 billion RMB [3]

Group 1 - The company held its 37th meeting of the sixth board of directors on November 10, 2025, where all resolutions were deemed legal and effective [1][2]. - The board approved the proposal to change the registered capital, abolish the supervisory board, and amend the Articles of Association [3][20]. - The company will cancel the supervisory board, transferring its powers to the audit committee of the board [3][50]. Group 2 - The company will repurchase and cancel a total of 21,007,000 shares, reducing the total share capital from 3,408,388,753 shares to 3,387,381,753 shares [4][22]. - The company also approved the repurchase and cancellation of 2,370,000 restricted shares due to the departure of seven incentive targets, reducing the total share capital from 3,410,758,753 shares to 3,408,388,753 shares [4][48]. Group 3 - The board approved the revision of the "Rules of Procedure for Shareholders' Meetings," renaming it to "Rules of Procedure for Shareholders' Meetings" [7][9]. - The board also approved the revision of the "Rules of Procedure for Board Meetings" [10][11]. - A series of internal governance documents were revised and approved, including the "President's Work Guidelines" and "Independent Director Work System" [11][12]. Group 4 - The company plans to hold its first extraordinary general meeting of shareholders on November 28, 2025, to discuss the approved proposals [16][28]. - The meeting will be conducted both in-person and via online voting, with specific time slots for each voting method [30][40].

新里程健康科技集团股份有限公司 第四条 独立董事应对公司拟聘任的会计师事务所以及为公司提供年度审计 的注册会计师（以下简称"年审注册会计师"）的从业资格进行核查。 第五条 公司财务总监应在年审注册会计师进场审计前向独立董事书面提交 本年度审计工作安排及其他相关材料。 第六条 公司应在年审注册会计师出具初步审计意见后和召开董事会会议审 议年报前，独立董事可以要求公司安排独立董事与年审注册会计师的见面会，沟 通审计过程中发现的问题。独立董事应履行见面的职责，并就沟通过程中发现的 问题与公司管理层进行沟通，分析问题成因，判断其风险程度，探求解决方案。 1 新里程健康科技集团股份有限公司 新里程健康科技集团股份有限公司 独立董事年报工作制度 第一条 为进一步完善公司治理机制，建立健全公司内部控制制度，提高信 息披露质量，明确独立董事职责，充分发挥独立董事在信息披露方面的作用，根 据《上市公司独立董事管理办法》《上市公司治理准则》《深圳证券交易所股票 上市规则》《深圳证券交易所上市公司自律监管指引第1号——主板上市公司规 范运作》的有关规定以及《新里程健康科技集团股份有限公司章程》（以下简称 "《公司章程》"）、《新里 ...

新里程健康科技集团股份有限公司 新里程健康科技集团股份有限公司 董事会审计委员会工作细则 第一章 总 则 第一条 为建立和健全新里程健康科技集团股份有限公司（以下简称"公司"） 内部控制制度，提高内部控制能力，完善内部控制程序，促进董事会对管理层进 行有效监督，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上 市公司治理准则》《上市公司独立董事管理办法》《深圳证券交易所股票上市规 则》《深圳证券交易所上市公司自律监管第1号——主板上市公司规范运作》等 法律、行政法规、部门规章、规范性文件及《新里程健康科技集团股份有限公司 章程》（以下简称"《公司章程》"）的有关规定，公司董事会下设董事会审计 委员会（以下简称"审计委员会"），并制定本工作细则。 第二条 审计委员会是公司董事会下设的专门委员会，向董事会负责并报告 工作。 审计委员会委员任期届满前，除非出现法律、法规、规范性文件或《公司章 程》规定的不得任职之情形，不得被无故解除职务。委员如不再担任公司董事职 务，则自动失去委员资格，并由董事会根据本工作细则第四条规定补足委员人数。 第三条 公司设立内部审计部门，对公司内部控制制度的建立和实施、公司 ...